Analysis of the Associations of Measurements of Body Composition and Inflammatory Factors with Cardiovascular Disease and Its Comorbidities in a Community-Based Study
Open Access
- 11 May 2024
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 12 (5) , 1066
Abstract
The associations of cardiovascular disease (CVD) with comorbidities and biochemical and body composition measurements are repeatedly described but have not been studied simultaneously. In the present cross-sectional study, information on CVD and comorbidities [type 2 diabetes mellitus (T2DM), hypertension (HTN), and hyperlipidemia (HDL)], body composition, levels of soluble markers, and other measures were collected from 1079 individuals. When we examined the association of each comorbidity and CVD, controlling for other comorbidities, we observed a clear pattern of the comorbidity-related specific associations with tested covariates. For example, T2DM was significantly associated with GDF-15 levels and the leptin/adiponectin (L/A) ratio independently of two other comorbidities; HTN, similarly, was independently associated with extracellular water (ECW) levels, L/A ratio, and age; and HDL was independently related to age only. CVD showed very strong independent associations with each of the comorbidities, being associated most strongly with HTN (OR = 10.89, 6.46–18.38) but also with HDL (2.49, 1.43–4.33) and T2DM (1.93, 1.12–3.33). An additive Bayesian network analysis suggests that all three comorbidities, particularly HTN, GDF-15 levels, and ECW content, likely have a main role in the risk of CVD development. Other factors, L/A ratio, lymphocyte count, and the systemic inflammation response index, are likely indirectly related to CVD, acting through the comorbidities and ECW.Keywords
Funding Information
- Israel Science Foundation (2054/19, RA2000000457)
- the Ariel University Research & Development Department (2054/19, RA2000000457)
This publication has 95 references indexed in Scilit:
- Growth differentiation factor-15 as a negative predictor for microvascular obstruction in ST-segment elevation myocardial infarction after primary percutaneous coronary interventionThe International Journal of Cardiovascular Imaging, 2024
- Hypertension in diabetesPediatric Nephrology, 2023
- Relevance of body composition in phenotyping the obesitiesReviews in Endocrine and Metabolic Disorders, 2023
- Scoliosis and skeletal muscle mass are strongly associated with low back pain‐related disability in humans: An evolutionary anthropology point of viewAmerican Journal of Human Biology, 2022
- Growth differentiation factor‐15 and the risk of cardiovascular diseases and all‐cause mortality: A meta‐analysis of prospective studiesClinical Cardiology, 2019
- Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and Cancer–Cardiovascular CohortDiabetologia, 2018
- The Different Facets of Dyslipidemia and Hypertension in AtherosclerosisCurrent Atherosclerosis Reports, 2016
- A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapyCancer, 2016
- Growth differentiation factor 15 as a useful biomarker for mitochondrial disordersAnnals of Neurology, 2015
- Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low‐grade inflammationDiabetes/Metabolism Research and Reviews, 2013